COVID-19 complicated by high Venous Thromboembolism (VTE) and bleed risk in critically ill patients.
Study reports abnormally high VTE and high bleed risk in critically ill COVID-19 patients and calls for more effective prevention strategies.
Clinicians at NHS hospitals are supporting the care of COVID-19 patients with the use of geko™ devices to reduce the risk of blood clots in the most at risk patients.
Through our central vision in driving innovation through collaborative partnerships to solve challenging medical problems, we have placed research at the heart of our business.
VTE prevention
The use of the geko™ device and the activation of the foot and calf pumps for prevention of venous thromboembolism in patients with acute stroke
Author(s): Natarajan I, Williams J, Richards, L, Moss C, Lambert C, Roffe C